SLC17A5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.563000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.573400E-01
Normal-vs-Stage2
2.380600E-01
Normal-vs-Stage3
5.289000E-01
Normal-vs-Stage4
1.001600E-01
Stage1-vs-Stage2
8.631600E-01
Stage1-vs-Stage3
8.393400E-01
Stage1-vs-Stage4
1.839220E-01
Stage2-vs-Stage3
9.119200E-01
Stage2-vs-Stage4
7.970000E-02
Stage3-vs-Stage4
5.125000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.735200E-01
Normal-vs-AfricanAmerican
1.984410E-01
Normal-vs-Asian
2.976200E-01
Caucasian-vs-AfricanAmerican
6.331200E-01
Caucasian-vs-Asian
4.873200E-01
AfricanAmerican-vs-Asian
9.693000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.803600E-01
Normal-vs-Female
2.379800E-01
Male-vs-Female
6.115000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.935400E-01
Normal-vs-Age(41-60Yrs)
1.462230E-01
Normal-vs-Age(61-80Yrs)
3.135800E-01
Normal-vs-Age(81-100Yrs)
3.067000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.684200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.154800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.067200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.289600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.508400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.602600E-01
Normal-vs-Daily Drinker
6.656000E-01
Normal-vs-Weekly Drinker
3.844600E-01
Normal-vs-Occasional Drinker
1.815550E-01
Normal-vs-Social Drinker
2.335800E-01
Non Drinker-vs-Daily Drinker
8.102200E-02
Non Drinker-vs-Weekly Drinker
6.259600E-01
Non Drinker-vs-Occasional Drinker
7.607400E-01
Non Drinker-vs-Social Drinker
4.713200E-01
Daily Drinker-vs-Weekly Drinker
2.611600E-01
Daily Drinker-vs-Occasional Drinker
7.753600E-02
Daily Drinker-vs-Social Drinker
2.066800E-01
Weekly Drinker-vs-Occasional Drinker
7.353200E-01
Weekly Drinker-vs-Social Drinker
9.453200E-01
Occasional Drinker-vs-Social Drinker
6.166600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.118000E-01
Normal-vs-Grade 2
7.070100E-02
Normal-vs-Grade 3
4.369700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.061600E-01
Grade 1-vs-Grade 3
2.977800E-01
Grade 1-vs-Grade 4
2.118000E-01
Grade 2-vs-Grade 3
8.199200E-01
Grade 2-vs-Grade 4
7.070100E-02
Grade 3-vs-Grade 4
4.369700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.333000E-01
Normal-vs-NonDiabetic
2.846800E-01
Diabetic-vs-NonDiabetic
3.154000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.375800E-01
Normal-vs-NoPancreatitis
3.061200E-01
Pancreatitis-vs-NoPancreatitis
3.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.264200E-01
Normal-vs-N1
2.730200E-01
N0-vs-N1
3.376200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.968970E-01
Normal-vs-TP53-NonMutant
2.259400E-01
TP53-Mutant-vs-TP53-NonMutant
6.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
